The study of ALS biomarker based on molecular dynamics of oxidative stress regulatory factor - ALS biomarker research

Faculty of Medicine, Kitasato University0 个研究点目标入组 60 人开始时间: 2014年2月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patient to whom the diagnosis has not been disclosed 2)Patient having severe psychiatric symptoms (hallucination, delusion) or dementia 3)Patient having serious orthostatic hypotension or other types of hypotension 4)Patient having a severe complication(s) such as heart, kidney and/or liver disease 5)Patient having the complications of the allergic disease that an acidophile level is easy to rise 6)Patient did not have ability to comprehend informed consent 7)Patient who was inappropriate for this study 8)Patient who has received an investigational drugs or devices within three months before 9) Patient who participates in other clinical trials *The patient treated with existing therapeutic drug does not correspond to exclusion criteria

发起方

Faculty of Medicine, Kitasato University